Lignans and Gut Microbiota: An Interplay Revealing Potential Health Implications

被引:64
|
作者
Senizza, Alice [1 ]
Rocchetti, Gabriele [1 ]
Mosele, Juana, I [2 ]
Patrone, Vania [1 ]
Callegari, Maria Luisa [1 ]
Morelli, Lorenzo [1 ]
Lucini, Luigi [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Dept Sustainable Food Proc, Via Emilia Parmense 84, I-29122 Piacenza, Italy
[2] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Analit & Fisicoquim, Catedra Fisicoquim, C1113AAD, Buenos Aires, DF, Argentina
来源
MOLECULES | 2020年 / 25卷 / 23期
关键词
phenolic compounds; bioaccessibility; enterolignans; gut microbiota; gut– brain axis; PLANT LIGNANS; MAMMALIAN LIGNANS; DIETARY LIGNANS; O-DEMETHYLASE; IN-VITRO; INTESTINAL BACTERIA; PHENOLIC-COMPOUNDS; URINARY-EXCRETION; BRAIN; ENTEROLACTONE;
D O I
10.3390/molecules25235709
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plant polyphenols are a broad group of bioactive compounds characterized by different chemical and structural properties, low bioavailability, and several in vitro biological activities. Among these compounds, lignans (a non-flavonoid polyphenolic class found in plant foods for human nutrition) have been recently studied as potential modulators of the gut-brain axis. In particular, gut bacterial metabolism is able to convert dietary lignans into therapeutically relevant polyphenols (i.e., enterolignans), such as enterolactone and enterodiol. Enterolignans are characterized by various biologic activities, including tissue-specific estrogen receptor activation, together with anti-inflammatory and apoptotic effects. However, variation in enterolignans production by the gut microbiota is strictly related to both bioaccessibility and bioavailability of lignans through the entire gastrointestinal tract. Therefore, in this review, we summarized the most important dietary source of lignans, exploring the interesting interplay between gut metabolites, gut microbiota, and the so-called gut-brain axis.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Complex interplay between the immune system and the infant gut microbiota: Potential health implications
    Jenmalm, Maria
    [J]. TOXICOLOGY LETTERS, 2016, 258 : S17 - S17
  • [2] Interplay between Lignans and Gut Microbiota: Nutritional, Functional and Methodological Aspects
    Baldi, Simone
    Asensi, Marta Tristan
    Pallecchi, Marco
    Sofi, Francesco
    Bartolucci, Gianluca
    Amedei, Amedeo
    [J]. MOLECULES, 2023, 28 (01):
  • [3] Interplay between food and gut microbiota in health and disease
    Danneskiold-Samsoe, Niels Banhos
    de Freitas Queiroz Barros, Helena Dias
    Santos, Rosangela
    Bicas, Juliano Lemos
    Betim Cazarin, Cinthia Bau
    Madsen, Lise
    Kristiansen, Karsten
    Pastore, Glaucia Maria
    Brix, Susanne
    Marostica Junior, Mario Roberto
    [J]. FOOD RESEARCH INTERNATIONAL, 2019, 115 : 23 - 31
  • [4] The Effect of COVID-19 on Gut Microbiota: Exploring the Complex Interplay and Implications for Human Health
    Akter, Shamima
    Tasnim, Sa'dia
    Barua, Rashu
    Choubey, Mayank
    Arbee, Shahida
    Mohib, Mohammad Mohabbulla
    Minhaz, Naofel
    Choudhury, Ajanta
    Sarker, Pallab
    Mohiuddin, Mohammad Sarif
    [J]. GASTROINTESTINAL DISORDERS, 2023, 5 (03): : 340 - 355
  • [5] Interplay of Food-Derived Bioactive Peptides with Gut Microbiota: Implications for Health and Disease Management
    Hu, Mingyang
    Du, Yufeng
    Li, Wenyue
    Zong, Xiaomei
    Du, Wenjuan
    Sun, Huizeng
    Liu, Hongyun
    Zhao, Ke
    Li, Jianxiong
    Farooq, Muhammad Zahid
    Wu, Jianping
    Xu, Qingbiao
    [J]. MOLECULAR NUTRITION & FOOD RESEARCH, 2024,
  • [7] Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies
    Corrie, Leander
    Awasthi, Ankit
    Kaur, Jaskiran
    Vishwas, Sukriti
    Gulati, Monica
    Kaur, Indu Pal
    Gupta, Gaurav
    Kommineni, Nagavendra
    Dua, Kamal
    Singh, Sachin Kumar
    [J]. PHARMACEUTICALS, 2023, 16 (02)
  • [8] The gut microbiota and potential health effects of intervention
    Björkstén, B
    [J]. PRIMARY PREVENTION BY NUTRITION INTERVENTION IN INFANCY AND CHILDHOOD, 2006, 57 : 81 - 92
  • [9] The Gut Microbiota and their Metabolites: Potential Implications for the Host Epigenome
    Mischke, Mona
    Plosch, Torsten
    [J]. MICROBIOTA OF THE HUMAN BODY: IMPLICATIONS IN HEALTH AND DISEASE, 2016, 902 : 33 - 44
  • [10] Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability
    Flowers, Stephanie A.
    Bhat, Shubha
    Lee, James C.
    [J]. PHARMACOTHERAPY, 2020, 40 (07): : 704 - 712